Event News
Press Release 3/09 |
| Posted by insynCVentures on Mar 02 2009 |
| Event News >> News Flash |
Pioneers in Cardiac, Vascular and Interventional Technologies, Thomas Fogarty, MD, and Manny Villafana, to Present at InsynCVentures Start-Up Conference, April 22 in Dallas
InsynCVentures draws innovators, leading venture capitalists and business development executives to the most valuable cardiovascular investment and partnering event of the year
IRVINE, CA – BUSINESS WIRE (March 3, 2009) – Sharon O’Reilly, founder of Medtech Insight and originator of the “Investment In Innovation (In3)” conference series, in conjunction with Michael Mack, MD, world renowned heart surgeon, are proud to announce that Thomas Fogarty, MD and Manny Villafana, founders of numerous well-known cardiac, vascular and interventional companies will be featured speakers at insynCVentures, a one-day strategic partnering and investment conference focused exclusively on circulatory start-ups. The insynCVentures event will be held on April 22, 2009 at the Westin Galleria Dallas, immediately before the Dallas-Leipzig International Valve Congress.
“With the scarcity of funding for medtech start-ups, many privately-held companies are in a survival mode,” reports O’Reilly. “By having our conference focused solely on privately-held companies in the cardiac, vascular and interventional space, our audience will be rich and deep with executives and investors from major CV companies and investment firms, making the insynCVentures conference an affordable and efficient way for emerging companies to get in front of the dealmakers they need to meet.”
The insynCVentures conference will also feature an all-day exhibit hall, and conclude with a panel of influential venture capitalists and business development executives from leading cardiovascular and interventional companies discussing alternative fundraising strategies in the current investment climate, entitled "CV Funding Strategies: Thinking Out of the Box." Participants include Allan May of Emergent Ventures and founder of Life Science Angels, Jeff Gold of Longitudinal Capital, Chad Cornell, Vice President, Corporate Development of Medtronic, and Monty Mars, Director, Corporate Development of Edwards Lifesciences.
The insynCVentures event will bring key dealmakers together in the cardiovascular arena—ranging from CEOs, Business Development, Strategic Planning, Acquisition and Marketing VPs, Entrepreneurs and Venture Capitalists. Early-stage companies developing technologies in the areas of Biologics and Regenerative Medicine; Cardiovascular Diagnostics; Cardiovascular Surgery; Interventional Cardiology; Electrophysiology; Heart Failure; Peripheral Vascular Interventions; and Stroke should not miss this opportunity.
Sponsors of the insynCVentures conference include: The Aubrey Group; Medmarc, The Hartford and BioMedicinsure; The MedTech Group; and MDMA. A regularly updated list of presenting companies can be found at www.insyncventuresconference.com.
To attend, or become a presenter at or sponsor of the insynCVentures event, please contact insynCVentures.
CONTACT:
Sharon O’Reilly or Tracy Neilssien
949-559-5511
info@insyncventuresconference.com
Last changed: Aug 28 2009
Back